MediBloc Joins KT and the Gates Foundation Research Consortium for Infectious Diseases Response
MediBloc has joined a research consortium invested in jointly by KT and the Bill & Melinda Gates Foundation.
This consortium consists of MediBloc and KT along with Korea University Hospital, Korea Institute of Science and Technology Information (KISTI), and Mobile Doctor. The consortium will conduct research on the “self-diagnosis of infectious diseases using ICT technology such as AI, big data, and communication data diffusion path prediction research” over the course of three years. The total investment will be KRW 12 billion (approx. USD $10 million), with the Gates Foundation and KT each investing half.
This joint research has succeeded in large part due to the Gates Foundation’s trust in Korea’s groundbreaking ICT technology and coronavirus disease control response capabilities.
The Bill & Melinda Gates Foundation is the world’s largest privately-owned, fully financially transparent foundation, with $46.8 billion in assets as of 2018. Because of the foundation’s considerable financial scale and advanced management practices in search of suitable donations to make, it is recognized as a leader among charities worldwide.
KT and MediBloc are concentrating on designing and building a medical data exchange system. We are planning to promote a more advanced PHR system by using a dynamic consent system, and we also plan to proceed with the stabilization of networks, including blockchain networks, so that medical data can be shared more smoothly between individuals. We will also develop a data-sharing system using the MediBloc blockchain network and a patient consent service.
KT plans to develop an application that will allow patients to self-center flu-like symptoms via mobile devices, and it will then, with their consent, use their data for research. Patients can use it for self-diagnosis by measuring whether their body temperature is normal and whether there is inflammation in their respiratory system, all via IoT sensors. Afterward, we will complete the algorithm by comparing an AI-based influenza symptom analysis and then use the results of hospital sample tests to derive a confirmation rate.
Through this joint research, we expect to improve the interoperability of personal health information between KT and other institutions and further improve the security of medical data. KT and Mobile Doctor will join other corporations in leveraging blockchain technology to store secure and accessible data with the patients’ consent, and we expect that this will allow them to use a broader range of patient health information to provide the best medical data care service in the PHR system.
Dr. Eunsol Lee, co-founder of MediBloc, said, “Collaborating with KT, one of the best ICT companies in Korea, and cooperating with the Gates Foundation, is an excellent opportunity for us to prove the feasibility of our platform as well as expand its scope. With this consortium, we will keep expanding our presence in the global market.”
The team will continue to expand its business globally and accelerate the commercialization of theMediBloc platform. We appreciate everyone’s continued support!
The MediBloc Team — MediBloc is a healthcare data platform based on blockchain technology and aims to promote the development of the medical industry and further improve the quality of human life. MediBloc has conducted agreements and PoCs with leading domestic and foreign medical institutions, including Woorisoa Children’s Hospital, Hanyang University Medical Center, Kyunghee University Dental Hospital, and Seoul National University Hospital. In addition, the company was selected for 2019 My Data Business and the 2019 Health Care related Government Tasks supported by the Korea Information Service Agency, a quasi-governmental organization within the Ministry of Science, Technology, Information and Communication, and released its blockchain-based real-loss insurance claim app MediPass in November 2019.